Potassium hydroxylamine complexes

Potassium complexes of N,N-dialkylhydroxylamines [KONR2, R=Me (1a), iPr (2a), CH2C6H5] were synthesized by the deprotonation of the corresponding N, N-dialkylhydroxylamines with KH. 1a and 1b [(KONMe2)(HONMe2)] dissolve in THF under the addition of an additional equiv of the parent hydroxylamine to give 1b and [(KONiPr2)(HONiPr2)(THF)] 2b. 1b, 2b and [(KONBn2)6(THF)4] (3) were characterized by NMR and IR spectroscopy, by elemental analyses, and by X-ray diffraction of single crystals. 1b and 2b crystallize as polymers, whereby compound 1b with smaller groups leads to higher coordination numbers at the potassium atoms (CN=7) and double-stranded more complex ladder-type aggregates, whereas 2b with the larger iPr groups contains potassium atoms with a coordination number of 5 and is a single-stranded polymer. The compound {[KON(CH2C6H5)2]6(THF)4} (3) exists in a hexameric bis-cubane-based form in the solid state. Quantum chemical calculations were undertaken to examine the nature of the hydrogen bonding in the (R2NO...H...ONR2) units of 1b and 2b, which is asymmetric in the first and symmetric in the second case.     

EPR, IR and electronic spectral studies on Ni(II) and Cu(II) complexes with N-donor tetradentate [N4] macrocyclic ligand

Nickel(II) and copper(II) complexes are synthesized with a novel tetradentate macrocyclic ligand, i.e. 2,6,12,16,21,22-hexaaza;3,5,13,15-tetraphenyltricyclo[15,3,1,1(7-11)] docosa;1(21),2,5,7,9,11(22),12,15,17,19-decaene (L) and characterized by the elemental analysis, magnetic susceptibility measurements, mass, (1)H NMR, IR, electronic and EPR spectral studies. All the complexes are non-electrolytic in nature. Thus, these may be formulated as [M(L)X(2)] [M=Ni(II), Cu(II) and X=Cl(-), NO(3)(-) and (1/2)SO(4)(2-)]. Ni(II) and Cu(II) complexes show magnetic moments corresponding to two and one unpaired electron, respectively. On the basis of IR, electronic and EPR spectral studies an octahedral geometry has been assigned for Ni(II) and tetragonal geometry for Cu(II) complexes.     

Solvation oscillations and excited-state dynamics of 2-amino- and 2-hydroxy-7-nitrofluorene and its 2'-deoxyriboside

Push-pull substituted fluorenes are considered for use as dynamic solvation probes in polynucleotides. Their fluorescence band is predicted (by simulations) to show weak spectral oscillations on the subpicosecond time scale depending on the nucleotide sequence. The oscillations reflect the local far-infrared spectrum of the environment around the probe molecule. A connection is provided by the continuum theory of polar solvation which, however, neglects molecular aspects. We examine the latter using acetonitrile solution as a test case. A collective librational solvent mode at 100 cm(-1) is observed with 2-amino-7-nitrofluorene, 2-dimethylamino-7-nitrofluorene, 2-hydroxy-7-nitrofluorene, and its 2'-deoxyriboside. Different strengths of the oscillation indicate that rotational friction of nearby acetonitrile molecules depends on the solute structure or that H bonding is involved in launching the librational coherence. Polar solvation in methanol is used for comparison. With hydroxynitrofluorenes, the observation window is limited by intersystem crossing for which rates are reported. A prominent excited-state absorption band of nitrofluorenes at 430 nm can be used to monitor polar solvation. Structural and electronic relaxation pathways are discussed with the help of quantum chemical calculations.     

2-Amino-7-nitro-fluorenes in neat and mixed solvents-optical band shapes and solvatochromism

Femtosecond transient absorption spectroscopy of amino-nitro-fluorenes in the UV-visible range shows that the dynamic Stokes shift of the emission band is sensitive to infrared-active modes of the solvent. Bandshapes for stationary absorption and emission are needed to quantify the observed spectral evolution. They are reported for 2-amino-7-nitro-fluorene (ANF), 2-dimethylamino-7-nitro-fluorene (dM-ANF), and 2-di(n-butyl)amino-7-nitro-9-di(n-propyl)-fluorene (dBdP-ANF) in a variety of solvents. Bands broaden systematically with increasing solvent polarity. This effect is taken into account in an improved location of band positions. The resulting solvatochromic plots differ significantly from those that use peak positions of absorption spectra and fluorescence quantum distributions. Absorption spectra were also measured in aqueous solvent mixtures, and shifts are described by binding curves for hydrogen bonding and stepwise solvent exchange.     

DNA vaccines for cervical cancer: from bench to bedside

More than 99% of cervical cancers have been associated with human papillomaviruses (HPVs), particularly HPV type 16. The clear association between HPV infection and cervical cancer indicates that HPV serves as an ideal target for development of preventive and therapeutic vaccines. Although the recently licensed preventive HPV vaccine, Gardasil, has been shown to be safe and capable of generating significant protection against specific HPV types, it does not have therapeutic effect against established HPV infections and HPV-associated lesions. Two HPV oncogenic proteins, E6 and E7, are consistently co-expressed in HPV-expressing cervical cancers and are important in the induction and maintenance of cellular transformation. Therefore, immunotherapy targeting E6 and/or E7 proteins may provide an opportunity to prevent and treat HPV-associated cervical malignancies. It has been established that T cell-mediated immunity is one of the most crucial components to defend against HPV infections and HPV-associated lesions. Therefore, effective therapeutic HPV vaccines should generate strong E6/E7-specific T cell-mediated immune responses. DNA vaccines have emerged as an attractive approach for antigen-specific T cell-mediated immunotherapy to combat cancers. Intradermal administration of DNA vaccines via a gene gun represents an efficient way to deliver DNA vaccines into professional antigen-presenting cells in vivo. Professional antigen-presenting cells, such as dendritic cells, are the most effective cells for priming antigen-specific T cells. Using the gene gun delivery system, we tested several DNA vaccines that employ intracellular targeting strategies for enhancing MHC class I and class II presentation of encoded model antigen HPV-16 E7. Furthermore, we have developed a strategy to prolong the life of DCs to enhance DNA vaccine potency. More recently, we have developed a strategy to generate antigen-specific CD4(+) T cell immune responses to further enhance DNA vaccine potency. The impressive pre- clinical data generated from our studies have led to several HPV DNA vaccine clinical trials.     

Unimolecular rectification of monolayers of CH3C(O)S-C14H28Q(+)-3CNQ(-) and CH3C(O)S-C16H32Q(+)-3CNQ(-) organized by self-assembly, Langmuir-Blodgett, and Langmuir-Schaefer techniques

The advantage of "self-assembly" (strong covalent binding to substrates) was combined with the advantage of Langmuir-Blodgett (LB) or Langmuir-Schaefer (LS) transfer to a solid substrate (quantitative transfer of monolayers to the substrate). The electrical rectification (asymmetric conduction) by a monolayer of thioacetylalkylquinolinium tricyanoquinodimethanide was critically compared when these molecules had been transferred, by such competing techniques, onto gold electrodes, and then covered by a "cold gold" pad electrode. Unimolecular rectification was observed in the expected directions in the LB and LS monolayers. The Self-Assembled Monolayers (SAMs) were disordered; macroscopic measurements of rectification were unsuccessful for the SAMs, but successful for the down-stroke LB and LS monolayers, whose orientation and potential bonding to the Au surface should be identical to that of an ideal SAM.     

An environmentally benign solvent/catalyst-free one-pot synthesis of N-substituted phthalimides via Aza-wittig reaction

For the first time an environmentally benign solvent/catalyst-free protocol for the synthesis of a variety of N-substituted phthalimides is submitted. It involves a one-pot coupling of nascent phosphazene generated in situ with phthalic anhydride. The protocol is novel in (1) avoiding toxic solvents, (2) no catalyst is employed and (3) no isophthalimide is formed as noted in the prevailing solution phase/catalysed methodology.